The DOI matches its Crossref record.
Tumor necrosis factor- alpha synergizes with IFN- gamma in mediating killing of Leishmania major through the induction of nitric oxide.
Abstract
CBA mice develop cutaneous lesions when infected with Leishmania major. The disease development was significantly reduced by injecting into the lesion a combination of rIFN-gamma and rTNF-alpha. The doses of IFN-gamma and TNF-alpha used were suboptimal in that either cytokine alone did not have any effect. The therapeutic effect of IFN-gamma and TNF-alpha in vivo is reflected in their ability to activate macrophages to kill the intracellular parasites in vitro. The macrophage leishmanicidal activity induced by TNF-alpha and IFN-gamma can be completely inhibited by a specific inhibitor (l-NG monomethyl arginine) of nitric oxide synthesis. There was a direct correlation between the intracellular killing of the parasites and the production of nitric oxide by the macrophages. In contrast, there was no correlation between leishmanicidal activity and superoxide production by macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is worth noting that IFNγ co-operates with other TH1 cell cytokines and acts synergistically to enhance their ability to eliminate pathogens31,32.”
From An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial (2024) · cites this paper as [32]
Citations
Cited by
Sorted by citations
Items 101–200 of 522
Mossman, K. L., Upton, C., & McFadden, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3031 · Cited by 94
Interleukin‐4 transgenic mice of resistant background are susceptible to Leishmania major infection
Leal, L. M. C. C., Moss, D. W., Kühn, R., Miiller, W., & Liew, F. Y. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230241 · Cited by 94
Self-citationDivergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis*
Ritter, U., & Körner, H. (2002) · Parasite Immunology · doi:10.1046/j.1365-3024.2002.00467.x · Cited by 93
Cytokine profiles in canine visceral leishmaniasis
Carrillo, E., & Moreno, J. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.310 · Cited by 89
Lead toxicity on non-specific immune mechanisms of freshwater fish Channa punctatus
Paul, N., Chakraborty, S., & Sengupta, M. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.03.017 · Cited by 90
Fonseca, S. G., Romão, P. R. T., Figueiredo, F., de Morais, R. H., Lima, H., Ferreira, S. H., & Cunha, F. Q. (2003) · European Journal of Immunology · doi:10.1002/eji.200320335 · Cited by 88
Qi, H., Ji, J., Wanasen, N., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.988-995.2004 · Cited by 88
Control of Leishmania major Infection in Mice Lacking TNF Receptors
Nashleanas, M., Kanaly, S. T., & Scott, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5506 · Cited by 86
Romão, P. R. T., Tovar, J., Fonseca, S. G., Moraes, R. H., Cruz, Â. K., Hothersall, J. S., Noronha-Dutra, A. A., Ferreira, S. H., & Cunha, F. Q. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000300006 · Cited by 85
Role of Cytokines in Tuberculosis
Flesch, I. E. A., & Kaufmann, S. H. E. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80364-5 · Cited by 85
KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
Goto, Y., Bhatia, A., Raman, V. S., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05024-11 · Cited by 84
“As TNF- synergizes with IFN- in killing Leishmania parasites (24), induction of Agspecific T cells capable of producing multiple cytokines upon Ag recall might be more beneficial for control of Leishmania infection than those producing a single cytokine, and such induction may be a good indicator of whether a vaccine…”
BackgroundThe Inducibly Expressed GTPase Localizes to the Endoplasmic Reticulum, Independently of GTP Binding
Taylor, G. A., Stauber, R. H., Rulong, S., Hudson, E., Pei, Y. V., Pavlakis, G. N., Resau, J. H., & Woude, G. F. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10639 · Cited by 84
Jardim, A., Funk, V. A., Caprioli, R. M., et al. (1995) · Biochemical Journal · doi:10.1042/bj3050307 · Cited by 84
Corradin, S. B., Fasel, N. J., Buchmüller-Rouiller, Y., Ransijn, A., Smith, J., & Mauël, J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230851 · Cited by 83
Tumor necrosis factor-α in human American tegumentary leishmaniasis
Da‐Cruz, A. M., de Oliveira, M. P., Luca, P. M. D., et al. (1996) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02761996000200019 · Cited by 83
“In experimental leishmaniasis TNF-α appears to play an important role in host defense (Titus et al. 1989, Liew et al. 1990a, b, 1991).”
BackgroundKawakami, K., Qifeng, X., Tohyama, M., Qureshi, M. H., & Saitô, A. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-870.x · Cited by 81
Adjuvants for Leishmania vaccines: from models to clinical application
Raman, V. S., Duthie, M. S., Fox, C. B., Matlashewski, G., & Reed, S. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00144 · Cited by 81
“…mice infected with L. major is associated with the development of Th1 cells that produce IFN-γ, which is necessary for activation of macrophages and the production of nitric oxide (NO), the key effector molecule for destroying intracellular amastigotes (Liew et al., 1990a,b; Stenger et al., 1994).”
BackgroundLehner, M. D., Schwoebel, F., Kotlyarov, A., Leist, M., Gaestel, M., & Härtung, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4667 · Cited by 82
Cytokines and immunological control of Eimeria spp.
Ovington, K. S., Alleva, L. M., & Kerr, E. (1995) · International Journal for Parasitology · doi:10.1016/0020-7519(95)00069-e · Cited by 82
Xu, D.-Z., McSorley, S. J., Tetley, L., et al. (1998) · PubMed · Cited by 78
Self-citationMice with STAT6-Targeted Gene Disruption Develop a Th1 Response and Control Cutaneous Leishmaniasis
Stamm, L. M., Räisänen-Sokolowski, A. K., Okano, M., Russell, M. E., David, J. R., & Satoskar, A. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6180 · Cited by 78
Kima, P. E., Soong, L., Chicharro, C., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261249 · Cited by 78
Samant, M., Gupta, R., Kumari, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900265 · Cited by 77
Cytokines in Leishmaniasis: A Complex Network of Stimulatory and Inhibitory Interactions
Bogdan, C., Gessner, A., & Röllinghoff, M. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80366-9 · Cited by 80
Yu, H. B., Karunakaran, K. P., Kelly, I., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002952 · Cited by 76
“TNF-a in combination with IFN-g can synergize to mediate killing of pathogens (27).”
BackgroundResponse of Leishmania chagasi promastigotes to oxidant stress
Wilson, M. E., Andersen, K. A., & Britigan, B. E. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.5133-5141.1994 · Cited by 75
“Macrophages harboring amastigotes can be activated to kill through both oxidative and non-H202-associated microbicidal mechanisms (27, 37).”
BackgroundDirect Pro-Inflammatory Effects of Prorenin on Microglia
Shi, P., Grobe, J. L., Desland, F. A., Zhou, G., Shen, X. Z., Shan, Z., Liu, M., Raizada, M. K., & Sumners, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092937 · Cited by 75
“However, it primes the cells to produce a much stronger effects to a second stimulation, such as elicited by LPS, Cytosine-phosphateguanosine (CpG) and TNFa [28–30].”
BackgroundGoto, Y., Bogatzki, L. Y., Bertholet, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.001 · Cited by 75
Immune responses during cutaneous and visceral leishmaniasis
Kedzierski, Ł., & Evans, K. J. (2014) · Parasitology · doi:10.1017/s003118201400095x · Cited by 73
Kole, L., Das, L., & Das, P. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314929 · Cited by 75
Ansari, N. A., Ramesh, V., & Salotra, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/506624 · Cited by 75
Physiological Rationale for Suppression of Fever
Mackowiak, P. A. (2000) · Clinical Infectious Diseases · doi:10.1086/317511 · Cited by 74
Genetic regulation of macrophage priming/activation: the Lsh gene story
Blackwell, J. M., Roach, T. I. A., Atkinson, S. E., Ajioka, J. W., Barton, C. H., & Shaw, M. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90032-6 · Cited by 74
Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Selvapandiyan, A., Dey, R., Gannavaram, S., Lakhal-Naouar, I., DUNCAN, R. C., Salotra, P., & Nakhasi, H. L. (2011) · Journal of Tropical Medicine · doi:10.1155/2012/631460 · Cited by 73
“In addition, TNFα was also shown to stimulate the action of IFNγ in the induction of nitric oxide production in macrophages to kill the parasite [61].”
BackgroundNO as an affector molecule of parasite killing: modulation of its synthesis by cytokines
Oswald, I. P., Wynn, T. A., Sher, A., & James, S. L. (1994) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/1367-8280(94)90083-3 · Cited by 73
Tsagozis, P., Karagouni, E., & Dotsika, E. (2003) · Parasite Immunology · doi:10.1111/j.0141-9838.2004.00672.x · Cited by 72
Fu, Y. K., Arkins, S., Li, Y. M., Dantzer, R., & Kelley, K. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.1.1-8.1994 · Cited by 71
“, with TNF-ot in increasing class I (25) and II (47) major histocompatibility complex gene expression, suppressing differentiation of several types of human hematopoietic progenitor cells (7), and killing Leishmania major (34); with granulocyte-macrophage colony-stimulating factor in promoting monocyte activation (22)…”
MethodSelf-citationModular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human Leishmaniasis
Das, S., Freier, A., Boussoffara, T., Das, S., Oswald, D., Losch, F., Selka, M., Sacerdoti‐Sierra, N., Schönian, G., Wiesmüller, K., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008222 · Cited by 72
Flamme, A. C. L., Scott, P., & Pearce, E. J. (2002) · Parasite Immunology · doi:10.1046/j.1365-3024.2002.00473.x · Cited by 71
Release of Tumor Necrosis Factor-α From Human Alveolar Macrophages is Decreased in Smokers
Yamaguchi, E., Itoh, A., Furuya, K., et al. (1993) · CHEST Journal · doi:10.1378/chest.103.2.479 · Cited by 71
Hop, H. T., Reyes, A. W. B., Huy, T. X. N., Arayan, L. T., Min, W., Lee, H.-J., Rhee, M. H., Chang, H. H., & Kim, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00437 · Cited by 71
“In addition, production of reactive oxygen species (ROS) and nitric oxide (NO) was also demonstrated to be controlled by TNF (Liew et al., 1990; Blaser et al., 2016); however, the actual functions of these effectors in Brucella clearance are still debatable (Jiang et al., 1993; Gross et al., 1998).”
BackgroundMencacci, A. (1998) · International Immunology · doi:10.1093/intimm/10.1.37 · Cited by 67
Greenwald, R. J., McAdam, A. J., van der Woude, D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.991 · Cited by 69
Jang, S. I., Hardie, L. J., & Secombes, C. J. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.6.943 · Cited by 68
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis
Santos, C. D. S., & Brodskyn, C. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00165 · Cited by 67
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Saraf, A., Gurjar, R., Kaviraj, S., Kulkarni, A., Kumar, D., Kulkarni, R., Virkar, R., Krishnan, J., Yadav, A., Baranwal, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02955-2 · Cited by 66
“It is worth noting that IFNγ co-operates with other T H 1 cell cytokines and acts synergistically to enhance their ability to eliminate pathogens 31,32 .”
Vaccination with Leishmania Hemoglobin Receptor–Encoding DNA Protects Against Visceral Leishmaniasis
Guha, R., Gupta, D., Rastogi, R., Rajagopal, V., Krishnamurthy, G., Bimal, S., Roy, S., & Mukhopadhyay, A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006406 · Cited by 66
Adapala, N. S., & Chan, M. M.-Y. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.90 · Cited by 66
Theodos, C. M., Povinelli, L., Molina, R., Sherry, B. A., & Titus, R. G. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2839-2842.1991 · Cited by 66
“(9, 10) have reported that rMuTNF can activate MX to destroy L.”
BackgroundIFN-γ Promotes Fas Ligand- and Perforin-Mediated Liver Cell Destruction by Cytotoxic CD8 T Cells
Roth, E., & Pircher, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1588 · Cited by 64
Brachelente, C., Müller, N., Doherr, M. G., Sattler, U., & Welle, M. M. (2005) · Veterinary Pathology · doi:10.1354/vp.42-2-166 · Cited by 65
Vaccines and vaccination strategies against human cutaneous leishmaniasis
Okwor, I., & Uzonna, J. E. (2009) · Human Vaccines · doi:10.4161/hv.5.5.7607 · Cited by 64
Cataneo, A. H. D., Tomiotto‐Pellissier, F., Miranda-Sapla, M. M., Assolini, J. P., Panis, C., Kian, D., Yamauchi, L. M., Simão, A. N. C., Casagrande, R., Pinge‐Filho, P., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108745 · Cited by 69
Xu, D., McSorley, S. J., Tetley, L., Chatfield, S. N., Dougan, G., Chan, W. L., Satoskar, A. R., David, J. R., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1285 · Cited by 80
Self-citationHo, J. L., He, S. H., Rios, M. J. C., & Wick, E. A. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.2.344 · Cited by 64
Rieder, G., Hofmann, J. A., Hatz, R. A., Stolte, M., & Enders, G. A. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00280 · Cited by 62
Skerrett, S. J., & Martin, T. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3236-3243.1996 · Cited by 63
Pereira, L. I. D. A., Dorta, M. L., Pereira, A. J. C. S., et al. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.81.378 · Cited by 62
Gomes, I. N., Calabrich, A., Tavares, R. D. S., et al. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00025-x · Cited by 62
“major by a mechanism dependent on TNF-a induction [18,31,37].”
BackgroundTomiotto‐Pellissier, F., Alves, D. R., Miranda-Sapla, M. M., de Morais, S. M., Assolini, J. P., Bortoleti, B. T. D. S., Gonçalves, M. D., Cataneo, A. H. D., Kian, D., Madeira, T. B., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.083 · Cited by 60
Schwarz, M., Radeke, H. H., Resch, K., et al. (1997) · Kidney International · doi:10.1038/ki.1997.482 · Cited by 60
Viral Infection Causes Rapid Sensitization to Lipopolysaccharide: Central Role of IFN-αβ
Nansen, A., & Thomsen, A. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.982 · Cited by 59
Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials
Varu, V. N., Tsihlis, N. D., & Kibbe, M. R. (2008) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322752 · Cited by 59
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Helyar, L., Bundschuh, D. S., Laskin, J. D., & Laskin, D. L. (1994) · Hepatology · doi:10.1002/hep.1840200621 · Cited by 59
Lonardoni, M. V. C., Russo, M., & Jancar, S. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6355-6361.2000 · Cited by 63
“The importance of NO in controlling Leishmania infection has been confirmed also in vivo, since mice treated with an inhibitor of NO synthesis, L-NAME, developed larger lesions with a higher parasite load than did untreated mice (21, 24).”
BackgroundCryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells
Naslund, P. K., Miller, W. C., & Granger, D. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1298-1304.1995 · Cited by 57
“Examples include Listeria monocytogenes (3, 5), Mycobacterium bovis (18, 50), Leishmania major (23, 24, 36), and Francisella tularensis (16).”
BackgroundFalcone, V., Bassey, E., Toniolo, A., Conaldi, P. G., & Collins, F. M. (1994) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1994.tb00447.x · Cited by 58
Goto, Y., Bhatia, A., Raman, V. S., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.079 · Cited by 57
“This appears due to a synergistic effect of these cytokines, especially IFN-γ and TNF-α, in the killing of parasites [28].”
BackgroundCosta, D. J., Favali, C. B. F., Clarêncio, J., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1298-1305.2004 · Cited by 56
“Treatment with TNF- results in a reduction of the lesion size and parasitic burden (22, 23, 41).”
BackgroundIdentifying vaccine targets for anti-leishmanial vaccine development
Sundar, S., & Singh, B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.894467 · Cited by 58
Feng, H., & Walker, D. H. (1993) · PubMed · Cited by 56
Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages
Carmo, É. V. D. S., Katz, S., & Barbiéri, C. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013815 · Cited by 55
“) donovani through the production of oxygen radicals and nitric oxide [27,28].”
BackgroundCerávolo, I. P., Chaves, A. C. L., Bonjardim, C. A., Sibley, L. D., Romanha, Á. J., & Gazzinelli, R. T. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2233-2240.1999 · Cited by 54
“Many of these microbiostatic-microbicidal functions induced by IFN-g have also been shown to be potentiated by tumor necrosis factor alpha (TNF-a) (16, 23).”
BackgroundUFMylation inhibits the proinflammatory capacity of interferon-γ–activated macrophages
Balce, D. R., Wang, Y., McAllaster, M. R., Dunlap, B. F., Orvedahl, A., Hykes, B. L., Droit, L., Handley, S. A., Wilen, C. B., Doench, J. G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011763118 · Cited by 58
Li, Y., Severn, A., Rogers, M. V., et al. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220223 · Cited by 54
Self-citationSei, J. J., Cox, K. S., Dubey, S. A., Antonello, J. M., Krah, D. L., Casimiro, D. R., & Vora, K. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00553 · Cited by 55
“The benefit of poly-functional T cells in protection against pathogens has been attributed by their: (a) ability to express higher levels of IFNγ on a per-cell basis than other populations (49, 57, 60, 64); (b) enhanced cytotoxicity due to secretion of both IFNγ and TNFα (65, 66); and (c) high IL-2-mediated proliferat…”
BackgroundWang, M., Qureshi, N., Soeurt, N., et al. (2001) · Microbial Pathogenesis · doi:10.1006/mpat.2001.0463 · Cited by 53
Urban, J. F., Fayer, R., Sullivan, C. A., et al. (1996) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(96)05708-x · Cited by 53
NF-κB1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major
Artis, D., Speirs, K. M., Joyce, K. L., Goldschmidt, M. H., Caamaño, J., Hunter, C. A., & Scott, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1995 · Cited by 53
Negrão‐Corrêa, D. A. (2001) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652001000500011 · Cited by 52
“The protective function of Th1 response was first characterized in Leishmania major infected mice (LIEW et al., 1990) and subsequently confirmed in Toxoplasma, Eimeria and Cryptosporidium infected mice (FINKELMAN & URBAN, 1992).”
BackgroundPLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania
Santos, D. M., Carneiro, M. W., de Moura, T. R., Soto, M., Luz, N. F., Prates, D. B., Irache, J. M., Brodskyn, C. I., Barral, A. M. P., Barral‐Netto, M., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.003 · Cited by 50
Carrillo, E., Ahmed, S. N., Goldsmith‐Pestana, K., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.036 · Cited by 51
“These higher levels of TNF-α are consistent with murine leishmaniasis model studies of both cutaneous and visceral diseases [58,59], where TNF-α has been shown to enhance the effects of IFN-γ in mediating parasite killing.”
ResultImmunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection
Pereira, W. C. E., Lonardoni, M. V. C., Grespan, R., Caparroz‐Assef, S. M., Cuman, R. K. N., & Bersani-Amado, C. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.09.009 · Cited by 50
The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain
Ritter, U., Mattner, J., Rocha, J. S., Bogdan, C., & Körner, H. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.008 · Cited by 53
Roles of Nitric Oxide in Surgical Infection and Sepsis
Johnson, M. L., & Billiar, T. R. (1998) · World Journal of Surgery · doi:10.1007/s002689900368 · Cited by 50
Gupta, R., Kumar, V., Kushawaha, P. K., Tripathi, C. D. P., Joshi, S. A., Sahasrabuddhe, A. A., Mitra, K., Sundar, S., Siddiqi, M. I., & Dube, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086073 · Cited by 50
“Transcripts of IFN-c and TNF-a, often reported to act in concert to activate iNOS for the production of NO [79], showed manifold increase in all the immunized groups of hamsters.”
BackgroundInterferon‐gamma and resistance to bacterial infections
Czarniecki, C. W., & Sonnenfeld, G. (1993) · Apmis · doi:10.1111/j.1699-0463.1993.tb00073.x · Cited by 50
“89); and production of effector molecules such as toxic oxygen and nitrogen intermediates (1, 2, 5 , 30, 31, 34, 37, 38, 49, 62, 63, 72, 113).”
BackgroundPhagocytosis enhances murine macrophage activation by interferon‐γ and tumor necrosis factor‐α
Corradin, S. B., Buchmüller-Rouiller, Y., & Mauël, J. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211036 · Cited by 49
Nico, D., Claser, C., Borja-Cabrera, G. P., et al. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000866 · Cited by 49
Kushawaha, P. K., Gupta, R., Tripathi, C. D. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035670 · Cited by 49
“The transcript of IFN-c, a signature cytokine of the Th1-type response having a dominant effect on macrophage microbicidal responses and other effector killing mechanisms, along with TNF-a, often reported to act in concert to activate iNOS for the production of NO [75,76], were found to be down-regulated [64] in infec…”
BackgroundSusceptibility to Intracellular Infections: Contributions of TNF to Immune Defense
Li, X., Körner, H., & Liu, X. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01643 · Cited by 49
Wolday, D., Akuffo, H., Demissie, A., et al. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5258-5264.1999 · Cited by 49
“Although TNF-a has been shown to mediate host protection against Leishmania (14), its uncontrolled production may result in pathology.”
BackgroundChang, Y. C., Cherniak, R., Kozel, T. R., Granger, D. L., Morris, L., Weinhold, L. C., & Kwon-Chung, K. J. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1584-1592.1997 · Cited by 48
“, IFN-g) with a microorganism results in synergism for cytotoxic functions, especially nitric oxide-mediated cytotoxicity (22).”
BackgroundAntimicrobial Properties of Nitric Oxide
DeGroote, M. A., & Fang, F. C. (2002) · Springer eBooks · doi:10.1007/0-306-46816-6_12 · Cited by 55
Birkland, T. P., Sypek, J. P., & Wyler, D. J. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.51.3.296 · Cited by 49
Antigen Presentation by Macrophages Harboring Intravesicular Pathogens
Overath, P., & Aebischer, T. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01473-8 · Cited by 48
Allenbach, C., Launois, P., Mueller, C., & Tacchini‐Cottier, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737662 · Cited by 48
Tumour Necrosis Factor and Associated Cytokines in the host's response to malaria
Richards, A. L. (1997) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00122-7 · Cited by 48
Kawakami, K., Qureshi, M. H., Koguchi, Y., et al. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1460 · Cited by 48
Nahrevanian, H. (2009) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702009000600010 · Cited by 47
Metadata
- Authors
- Liew, F. Y., Li, Y., & Millott, S.
- Affiliations
- Wellcome Trust (GB)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-12
- Volume
- 145
- Issue
- 12
- Pages
- 4306-4310
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1739247159
- Cited by
- 522
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 16 · 2019: 7 · 2018: 14 · 2017: 16 · 2016: 11 · 2015: 13 · 2014: 21 · 2013: 16 · 2012: 15
- FWCI
- 37.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- Leishmania major, cutaneous leishmaniasis, TNF-α, interferon-gamma, nitric oxide, macrophage activation, antileishmanial activity, L-NG-monomethylarginine, superoxide, cytokine synergy
- MeSH terms
- Animals, Arginine, Cytotoxicity, Immunologic, Drug Synergism, Hydrogen Peroxide, Immunity, Cellular, Interferon-gamma, Leishmania tropica, Leishmaniasis, Macrophages, Mice, Inbred CBA, Nitric Oxide, Nitrites, Superoxides, Tumor Necrosis Factor-alpha, omega-N-Methylarginine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review